Fosun IPO set to broaden Hong Kong equity markets

Acquisitive conglomerate launches an IPO for Israel-based Sisram Medical, a company it acquired four years ago during the early stage of China’s overseas M&A boom.

Fosun Group is on course to plant a new marker for Hong Kong’s equity markets following the launch of an initial public offering in Sisram Medical this Thursday.

The IPO, which will raise up to HK$1.35 billion $174 million, is the first example of a Chinese company listing one of its offshore assets back home. It will also represent the first Israeli company to list in Hong Kong.

Sisram Medical is a special purpose vehicle established in 2013 after Fosun’s $240 million acquisition of Alma Lasers, an Israel-based developer of laser devices for aesthetic and medical use.

As...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222